Bausch Health(BHC)
搜索文档
Bausch Health(BHC) - 2022 Q3 - Earnings Call Transcript
2022-11-03 23:39
Bausch Health Companies Inc. (NYSE:BHC) Q3 2022 Earnings Conference Call November 3, 2022 8:00 AM ET Company Participants Christina Cheng - Senior Vice President, Investor Relations and Communications Thomas Appio - Chief Executive Officer Tom Vadaketh - Chief Financial Officer Conference Call Participants Gary Nachman - BMO Capital Markets Georgi Yordanov - Cowen Umer Raffat - Evercore Greg Fraser - Truist Securities Douglas Miehm - RBC Capital Markets Rishi Parekh - JPMorgan Operator Good morning, ladies ...
Bausch Health(BHC) - 2022 Q3 - Quarterly Report
2022-11-03 00:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-14956 Bausch Health Companies Inc. (Exact name of registrant as specified in its charter) British Columbia , Canada 98-0448205 (State ...
Bausch Health(BHC) - 2022 Q2 - Earnings Call Transcript
2022-08-10 00:15
Bausch Health Companies Inc. (NYSE:BHC) Q2 2022 Earnings Conference Call August 9, 2022 8:00 AM ET Company Participants Christina Cheng - Senior Vice President, Investor Relations Thomas Appio - Chief Executive Officer Tom Vadaketh - Chief Financial Officer Conference Call Participants Ken Cacciatore - Cowen & Company Annabel Samimy - Stifel Gary Nachman - BMO Greg Fraser - Truist Securities Umer Raffat - Evercore Sahil Dhingra - RBC Operator Good morning and welcome to the Bausch Health Second Quarter 2022 ...
Bausch Health(BHC) - 2022 Q2 - Earnings Call Presentation
2022-08-10 00:02
BAUSCH Health Second Quarter 2022 Earnings Call August 9th, 2022 Forward-looking statements 2 This presentation contains forward-looking information and statements, within the meaning of applicable securities laws (collectively, "forward-looking statements"), including, but not limited to, statements regarding future prospects and performance of Bausch Health Companies Inc. ("Bausch Health", the "Company", "we", "us", "BHC"), including: the Company's revised 2022 full-year guidance; expectations for adjuste ...
Bausch Health(BHC) - 2022 Q2 - Quarterly Report
2022-08-09 00:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-14956 Bausch Health Companies Inc. (Exact name of registrant as specified in its charter) British Columbia , Canada 98-0448205 (State or ot ...
Bausch Health Companies Inc. (BHC) Management on Barclays High Yield Bond & Syndicated Loan Conference (Transcript)
2022-05-25 04:23
Bausch Health Companies Inc. (NYSE:BHC) Barclays High Yield Bond & Syndicated Loan Conference May 24, 2022 12:00 PM ET Company Participants Tom Vadaketh - Chief Financial Officer Will Woodfield - Treasurer Conference Call Participants Sean Palmer - Barclays Sean Palmer Great. Thanks, everyone, for joining. For those who don't know me, Sean Palmer from Barclays, subbing in for Rishi today. To my left, I have Tom Vadaketh, CFO of Bausch Health, and Will Woodfield, Treasurer of Bausch Health. Thanks, everyone, ...
Bausch Health(BHC) - 2022 Q1 - Earnings Call Presentation
2022-05-11 02:18
1Q 22 Financial Results BAUSCH-Health Forward-Looking Statements 1 This presentation contains forward-looking information and statements, within the meaning of applicable securities laws (collectively, "forward-looking statements"), including, but not limited to, statements regarding future prospects and performance of Bausch Health Companies Inc. ("Bausch Health", the "Company", "we", "us", "BHC"), including: the Company's 2022 full-year guidance; expectations for adjusted cash flows from operations and th ...
Bausch Health(BHC) - 2022 Q1 - Earnings Call Transcript
2022-05-10 21:56
Bausch Health Companies Inc. (NYSE:BHC) Q1 2022 Earnings Conference Call May 10, 2022 8:00 AM ET Company Participants Joe Papa - Chairman and Chief Executive Officer Thomas Appio - Chief Executive Officer, Bausch Health Tom Vadaketh - Chief Financial Officer, Bausch Health Conference Call Participants Ken Cacciatore - Cowen & Company Chris Schott - JPMorgan Doug Miehm - RBC Capital Markets Greg Fraser - Truist Securities Gary Nachman - BMO Capital Markets Operator Good day, and welcome to the Bausch Health ...
Bausch Health(BHC) - 2022 Q1 - Quarterly Report
2022-05-10 00:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-14956 Bausch Health Companies Inc. (Exact name of registrant as specified in its charter) British Columbia , Canada 98-0448205 (State or o ...
Bausch Health Companies Inc. (BHC) CEO Joe Papa Presents at 2022 Barclays Global Healthcare Conference (Transcript)
2022-03-16 02:32
Bausch Health Companies Inc. (NYSE:BHC) 2022 Barclays Global Healthcare Conference March 15, 2022 11:15 AM ET Company Participants Joe Papa - Chairman, CEO Conference Call Participants Darren Campili - Barclays Darren Campili Hi, I'm Darren Campili. Welcome to the Bausch Health Presentation. I am a Vice Chairman in the healthcare group and welcome, everybody. I'm here with Joe Papa, Chairman and Chief Executive Officer of Bausch Health. Joe Papa Hi, everyone. Darren Campili Perhaps, I'll kick it off with s ...